Measles mumps and rubella virus vaccine - GlaxoSmithKline
Alternative Names: 209762; GSK-209762; MMR vaccine - Bio-Manguinhos; MMR vaccine - GlaxoSmithKline; Priorix; SB-209762Latest Information Update: 16 Jun 2022
At a glance
- Originator GlaxoSmithKline
- Developer GlaxoSmithKline; GSK
- Class Measles vaccines; Mumps vaccines; Rubella vaccines; Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Measles; Mumps; Rubella